- Fellowship - Mayo Clinic (2017-2018), Advanced Radiation Oncology
- Residency - McGill University Health Centre (2012-2017), Radiation Oncology
- Medical School - Université Laval, Canada (2007-2012)
Aurelie Garant, M.D.
- Radiation Oncology
- Genitourinary Cancer
- Kidney Cancer
Aurelie Garant, M.D., is an Assistant Professor of Radiation Oncology at UT Southwestern Medical Center. She is board certified in radiation oncology by the American Board of Radiology.
Dr. Garant earned her medical degree at Université Laval, Canada, followed by a residency at McGill University Health Centre and a fellowship at Mayo Clinic in advanced radiation oncology. In 2015, she received the McGill University Residency Program award, and in 2017, the John D. Earle Fellowship at the Mayo Clinic.
In 2020, Dr. Garant received a Diploma of the Royal College of Physicians and Surgeons of Canada for focused competency in brachytherapy.
- Texas Super Doctors, Rising Star 2022
- Texas Super Doctors, Rising Star 2021
- Texas Super Doctors, Rising Star 2020
- NIH Kidney Cancer SPORE Career Enhancement Program Award 2019
- UT Southwestern Leaders Emerging in Academic Departments (LEAD) Course: Class of 2019 2019
- Reviewer (by invitation), International Journal of Radiation Oncology Biology Physics 2018
- American Brachytherapy Society Prostate LDR/HDR Scholarship 2018
- John D. Earle Radiation Oncology Fellowship Fund, Mayo Clinic, Rochester MN 2017-2018
- McGill University Residency Program Award – Scholar 2015-2016
- CIHR Travel Award Recipient for research presented abroad 2015
- McGill University Residency Program Award – Collaborator/Manager 2014-2015
- Chief Resident, Radiation Oncology Residency Program, McGill University, Canada 2014-2015
Surgical Techniques in Rectal Cancer in Neoadjuvant Radiotherapy
Vuong T, Garant A (2018), New York City, Springer
Current Therapy in Colon and Rectal Surgery in Cancer of the Rectum: Neoadjuvant Therapy
Vuong T, Garant A, Niazi T (2016), Amsterdam, Elsevier Sciences
- Surgical Techniques in Rectal Cancer in Neoadjuvant Radiotherapy
Image-guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer
Garant A, Magnan S, Devic S, Martin AG, et al International Journal of Radiation Oncology ? Biology ? Physics 2019 105 5 1005-1011
Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer
Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman IA, Singla N, Hammers H, Courtney KD, Bagrodia A, Margulis V, Desai NB, Garant A, Choy H, Timmerman RD, Brugarolas JB, Hannan R. International Journal of Radiation Oncology ? Biology ? Physics 2019 105 2 367-375
A comparison of patient-reported health-related quality of life during proton versus photon chemoradiotherapy for esophageal cancer
Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon SS, Merrell KW, Haddock MG, Hallemeier CL Practical Radiation Oncology 2019 9 6 410-417
Addition of iodinated contrast to rectal hydrogel spacer to facilitate MRI-independent target delineation and treatment planning for prostate cancer
Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB Practical Radiation Oncology 2019 9 6 528-533
Optimization of HDRBT boost dose delivery for patients with rectal cancer
Devic S, Bekerat H, Garant A, Vuong T Brachytherapy 2019 18 4 559-563
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
Paliga A, Onerheim R, Gologan A, Chong G, Spatz A, Niazi T, Garant A, Macheto D, Alcindor T, Vuong T British journal of cancer 2012 Nov 107 11 1864-8
Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer.
Yau I, Vuong T, Garant A, Ducruet T, Doran P, Faria S, Liberman S, Richard C, Letellier F, Charlebois P, Loungnarath R, Stein B, Devic S International journal of radiation oncology, biology, physics 2009 Aug 74 5 1481-6
What Is the Optimal Radiation Technique for Esophageal Cancer? A Dosimetric Comparison of Four Techniques.
Fawaz ZS, Kazandjian S, Tsui JM, Devic DS, Lecavalier-Barsoum M, Vuong T, Elakshar S, Garant A, Lavoie I, Niazi TM Cureus 2018 Jul 10 7 e2985
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.
Siddiqui MRS, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, Vuong T, Artho G, Rasheed S, Tekkis P, Abulafi AM, Brown G British journal of cancer 2017 Jun 116 12 1513-1519
Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N Clinical lung cancer 2017 09 18 5 565-571
Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G Annals of surgical oncology 2012 Apr 19 4 1199-205
Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review.
Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T Critical reviews in oncology/hematology 2017 Dec 120 86-92
Intensity-modulated radiation therapy for patients with rectal cancer.
Vuong T, Garant A Colorectal Cancer 2014 3 4 235-238
Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
Garant A, Des Groseilliers S, Martin L, Ferland É, Vuong T Clinical oncology (Royal College of Radiologists (Great Britain)) 2011 Sep 23 7 497-8
A comparison of grade 4 lymphopenia with proton versus photon radiotherapy for esophageal cancer. Advances in radiation oncology
Routman DM, Garant A, Lester SC, Cristobal CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW 2019 4 1 63-69
Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?
Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T International journal of colorectal disease 2018 Jun 33 6 727-733
Whole Abdominal-Pelvic Radiotherapy in the Management of Primary Ewing Sarcoma of the Peritoneal Cavity.
Barbosa Neto O, Garant A, Shakir S, Brossard J, Garde-Granger P, Freeman C Cureus 2016 Jan 8 1 e455
Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy.
McLaughlin MF, Folkert MR, Timmerman RD, Hannan R, Garant A, Hudak SJ, Costa DN, Desai NB, Advances in radiation oncology 2021 Jul-Aug 6 4 100713
Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.
Miranda AF, Howard JM, McLaughlin M, Meng X, Clinton T, Sanli Ö, Garant A, Bagrodia A, Margulis V, Lotan Y, Hannan R, Desai N, Woldu SL, Urologic oncology 2021 Jun
Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial.
Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, TimmermanMD RD, International journal of radiation oncology, biology, physics 2021 Nov
Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial.
Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2021 02 155 237-245
Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity.
Liang Y, Hannan R, Fu YX, Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Mar
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma.
Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, Advances in radiation oncology 2021 Sep-Oct 6 5 100692
Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer.
Chen L, Gannavarapu BS, Desai NB, Folkert MR, Dohopolski M, Gao A, Ahn C, Cadeddu J, Bagrodia A, Woldu S, Raj GV, Roehrborn C, Lotan Y, Timmerman RD, Garant A, Hannan R, Frontiers in oncology 2022 12 779182
Stereotactic Ablative Radiotherapy for Oligoprogressive Renal Cell Carcinoma, Advances in Radiation Oncology
Schoenhals J, Mohamad O, Christie A, Zhang Y, Singla N, Bowman IA, Hammers HJ, Courtney KD, Cole S, Bagrodia A, Margulis V, Desai NB, Garant A, Choy H, Timmerman RD, Brugarolas J, Hannan R Advances in Radiation Oncology 2001 6 5 100692
Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation.
Desai NB, Garant A, Hannan R, Folkert MR, International journal of radiation oncology, biology, physics 2020 11 108 4 914-916
Dosimetric impact of physician style variations in contouring CTV for post-operative prostate cancer: A deep learning-based simulation study
Balagopal A, Nguyen D, Mashayekhi M, Morgan H, Garant A, Desai N, Hannan R, Lin M.H., Jiang S arXiv 2021
PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumes.
Balagopal A, Morgan H, Dohopolski M, Timmerman R, Shan J, Heitjan DF, Liu W, Nguyen D, Hannan R, Garant A, Desai N, Jiang S, Artificial intelligence in medicine 2021 11 121 102195
A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy.
Balagopal A, Nguyen D, Morgan H, Weng Y, Dohopolski M, Lin MH, Barkousaraie AS, Gonzalez Y, Garant A, Desai N, Hannan R, Jiang S, Medical image analysis 2021 May 72 102101
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, International journal of radiation oncology, biology, physics 2019 10 105 2 367-375
Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer.
Garant A, Magnan S, Devic S, Martin AG, Boutros M, Vasilevsky CA, Ferland S, Bujold A, DesGroseilliers S, Sebajang H, Richard C, Vuong T, International journal of radiation oncology, biology, physics 2019 12 105 5 1005-1011
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer.
Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL, Practical radiation oncology 2019 Nov 9 6 410-417
The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer.
Dohopolski M, Hannan R, Wardak Z, Hammers H, Garant A, Cancer journal (Sudbury, Mass.) 2020 Sep/Oct 26 5 448-459
Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer.
Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB, Practical radiation oncology 2019 Nov 9 6 e528-e533
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.
Hannan R, Christensen M, Hammers H, Christie A, Paulman B, Lin D, Garant A, Arafat W, Courtney K, Bowman I, Cole S, Sher D, Ahn C, Choy H, Timmerman R, Brugarolas J, European urology oncology 2021 Dec
A Multi-institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.
Garant A, Spears G, Routman D, Whitaker T, Liao Z, Harmsen W, Liu A, Haddock M, Hallemeier C, Lin S, Merrell K, Practical radiation oncology 2021 Jan
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC.
All S, Garant A, Hannan R, Seminars in radiation oncology 2021 Jul 31 3 227-234
- Image-guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer
- RCC spine metastases
- Bladder cancer in women
- Prostate cancer protocols
- Rectal cancer in elderly patients
- Genitourinary Cancer
- Kidney Cancer
- Prostate Cancer